Trading Options with an Edge
Select Page

TCDA

Search by
TICKER SYMBOL

Tricida Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

10.86

0.04

(0.37%)

Volume:

0

52 week range:

3.8 - 12.45

Market Cap:

601.914M

Company Description:

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting a renal outcomes clinical trial, VALOR-CKD, to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. There are no FDA-approved treatments for chronic metabolic acidosis, a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. It is estimated to pose a health risk to approximately three million patients with CKD in the United States.